SCHEMBL7266155

SCHEMBL7266155

COc1cccc(F)c1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA7 P43166 2/20 0.42
CA9 Q16790 2/20 0.42
CA14 Q9ULX7 2/20 0.42
CA4 P22748 1/20 0.42
AR P10275 2/20 0.41
SMN1; SMN2 Q16637 4/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39
HPGD P15428 2/20 0.39
MAPK1 P28482 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10659718 0.87 CA1 (0.50) NFE2L2L3MBTL1TDP1CA12CA1
SCHEMBL8220456 0.83 NFE2L2 (0.44) NFE2L2L3MBTL1TDP1CA12CA1
SCHEMBL3102853 0.80 L3MBTL1 (0.44) NFE2L2L3MBTL1TDP1CA12CA1
SCHEMBL9952870 0.79 AR (0.44) NFE2L2CA12CA1CA2CA7
SCHEMBL16952213 0.79 CA1 (0.42) NFE2L2CA12CA1CA2CA7
SCHEMBL11143737 0.79 CA1 (0.42) NFE2L2L3MBTL1TDP1CA12CA1
SCHEMBL22024139 0.79 L3MBTL1 (0.43) NFE2L2L3MBTL1TDP1CA12CA1
SCHEMBL25021539 0.78 SMN1; SMN2 (0.41) NFE2L2TDP1CA12CA1CA2
SCHEMBL16952210 0.78 CA1 (0.41) NFE2L2L3MBTL1TDP1CA12CA1
SCHEMBL19949269 0.78 CA12 (0.41) NFE2L2L3MBTL1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117715892-A Quaternary ammonium cation substituted compounds for the treatment of bacterial infections 豪夫迈·罗氏有限公司 2024-03-15 CN disclosed
EP-0174131-A2 Dihydropyridines, processes and intermediates for their production, and pharmaceutical formulations containing them FISONS plc (GB) 1986-03-12 EP disclosed